Are Breast Cancers Diagnosed Soon After a Normal Mammogram More Aggressive?
An interval breast cancer is diagnosed after a mammogram that did not identify cancer but before the next routine screening and are considered screen failures. These cancers may have been hidden on the original mammogram or developed between screenings. Understanding why interval cancers develop and how they behave is vital for refining screening schedules.
Clinical guidelines differ regarding screening frequency. Major medical organizations recommend either annual mammograms starting at age 40 or 45, or biennial screening every two years starting at age 40. These conflicting recommendations leave women and physicians uncertain about optimal screening intervals, particularly for women with dense breast tissue.
Study Description
In this study, researchers investigated whether cancers diagnosed within the first year after BI-RADS 1, 2, or 3 assessments on screening mammography differed from those diagnosed during the second year, particularly in women with dense breasts. Interval cancers included those detected because of symptoms but some have been detected by supplemental screening MRI or ultrasound, though details of supplemental screening were not provided.
Researchers conducted a retrospective study using linked records from the Utah Population Database, Utah Cancer Registry, and two major healthcare systems. The study evaluated 149,769 women aged 38 to 79 receiving screening mammograms between 2005 and 2019. Researchers identified 2,122 women diagnosed with interval breast cancer within 24 months of a normal mammogram. They compared cancers diagnosed >1 to 12 months (early interval cancer) with those diagnosed at 13 to <24 months, with respect to breast density, age, tumor size, stage, lymph node involvement, and molecular subtype.
Key Findings
- Early interval cancers had more aggressive biological features than those detected in the second year after a clear mammogram.¹
- Early interval cancer were significantly more likely to have spread to nearby lymph nodes or distant organs.²
- Aggressive cancer subtypes, including HER2-positive and triple-negative breast cancers, were far more frequent in early interval cases.³
- Women under age 70 had a higher likelihood of developing an early interval cancer compared to older women.⁴
- Extremely dense breasts doubled the likelihood that an interval cancer appear within the first 12 months rather than the second.⁵
Interpretation/Implications
Based on the results, the authors recommend annual rather than biennial mammography for women younger than 70 or with dense breasts. The authors recommend women with dense breasts should also discuss supplemental screening with MRI or ultrasound.
Limitations
The predominantly White Utah population limits generalizability, and it was not detailed how many interval cancers were found on supplemental screening vs. because of symptoms. Future prospective studies in broader populations are needed.
Detailed Results
1 Early interval cancers (>1–12 months) comprised 22.9% of cases (486/2,122), while late interval cancers (13–<24 months) comprised 77.1% (1,636/2,122); early cases presented with larger tumor size (>20 mm in 39.1% vs 20.2%) and higher grade.
2 Compared to late interval cancers, early interval cancers showed higher odds of axillary node metastasis (OR = 1.68, 95% CI: 1.29–2.19, P < 0.01) and distant stage IV metastatic disease (OR = 4.07, 95% CI: 2.03–8.29, P < 0.01) at diagnosis.
3 Women with early interval cancers had increased odds of HER2-positive tumors (OR = 2.10, 95% CI: 1.36–3.22, P < 0.01) and triple-negative tumors (OR = 2.08, 95% CI: 1.26–3.39, P < 0.01) compared to 13–24-month cases.
4 Younger age was strongly associated with early interval cancer: age 38–49 years had an OR of 2.34 (95% CI: 1.61–3.40), age 50–59 had an OR of 1.88 (95% CI: 1.37–2.59), and age 60–69 had an OR of 1.67 (95% CI: 1.23–2.27) compared to age 70–79 (all P < 0.01).
5 Women with extremely dense breasts at index screening had twice the odds of developing early interval cancer compared to those with fatty breasts (OR = 2.05, 95% CI: 1.13–3.80, P = 0.02).

